Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Ardelyx Reports Successful Phase 3 T3MPO-1 Trial of Tenapanor in Patients with IBS-C

americanpharmaceuticalreviewMay 15, 2017

Tag: Tenapanor , IBS-C

PharmaSources Customer Service